Clinical Studies with Cancer Patients
Ovosan has been administered to thousands of patients with cancer of various types and stages and their progress has been monitored. In most cases, Ovosan has been used as a complementary supplement therapy alongside standard oncology treatments such as chemotherapy and radiotherapy. Some of the results are described in the book.
Here are the highlights:
- Generally, the results have concluded that patients have tolerated the standard chemotherapy and radiotherapy treatments better.
- Most patients, including children, had better appetites, maintained healthy weight and felt better.
- One of the promising highlights was that in a small group of patients with stage IV inoperable pancreatic cancer, the average survival time doubled compared to expectations.
- Another promising result was a successful treatment of a few patients with inoperable brain cancer, where the oncologists felt Ovosan was crucial element in the recovery of the patients.
To summarize, Ovosan complementary support significantly improved quality of life in oncology patients and has contributed to successful oncology treatment and recovery. The clinical studies should continue to map and quantify all the possible benefits that Ovosan (and CellBB) can offer.
Clinical study with psoriasis and atopic eczema patients
Summary: Over 40 patients@3-6 months study; 6 capsules of Ovosan daily + topical gel (with bio-active phospholipids).
Main conclusion:
- Generally positive effect of Ovosan has been observed in patients with different types of psoriasis including
the most severe cases - Despite the significant improvements observed in all patients, the study did not lead to full recovery,
possibly due to the short duration of the study and continuous dosing for only three months. - Very positive effect of Ovosan in atopic eczema patients, with several cases leading to full healing
Clinical study with psoriasis and atopic eczema patients
Summary: Over 40 patients@3-6 months study; 6 capsules of Ovosan daily + topical gel (with bio-active phospholipids).
Main conclusion:
- Generally positive effect of Ovosan has been observed in patients with different types of psoriasis including
the most severe cases - Despite the significant improvements observed in all patients, the study did not lead to full recovery,
possibly due to the short duration of the study and continuous dosing for only three months. - Very positive effect of Ovosan in atopic eczema patients, with several cases leading to full healing
Detailed Background information
| Psoriasis | Condition change | Out of 20 patients |
|---|---|---|
| Skin overall quality | At least moderate Improvement | 100% |
| The extent of skin coverage | Significant Improvement Moderate Improvement | 80% 20% |
| Healing | Significant Improvement Moderate Improvement | 80% 20% |
| Erytherm (redness) | Moderate improvement Small Improvement | 50% 50% |
| Itching | Moderate improvement Small Improvement | 60% 40% |
| Pain in joints | Significant Improvement | 100% |
Study details:
Psoriasis:
Psoriasis-localized: 10 patients
Generalized psoriasis: 5+ patients
Psoriatic Arthritis: 5 patients
Atopic Eczema:
10 adults and 10 children
Principal Investigator additional comments (Dr. Cabalová):
Atopic Eczema:
Generally positive results, skin was softer and better hydrated Patients both on ointment and capsules were better
Psoriasis
In all 10 patients with localized psoriasis a quick disappearance of
centers of psoriatic infiltration was observed between 1 or 3 months
This effect persisted until the last checkup .3 out of 10 patients
experienced remission after the study.
The 3 months application was too short, especially in the severe cases
of psoriasis
Study details
- Duration: 6 months
- Checkup every month, or after the 2 months pause
- Dosing: Ovosan based Topical gel & Ovosan capsules (6 capsules/day)
- Ovosan Capsules taken continuously first three months, then 2 month
pause, then one month again
Conclusion:
Generally positive effect in majority of patients. Significant improvement in most cases. Not fully cured and remission in some cases, but PI notes the study was too short.
Generalized Psoriasis
Start
3 months
6 months
Generalized Psoriasis
Start
3 months
6 months
Psoriasis
Start
6 months
Atopic Eczema
